Applied Therapeutics Inc (APLT)
Applied Therapeutics Inc
(APLT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 18,850 | N/A | N/A | N/A |
| Marketable Securities | 20,004 | N/A | N/A | N/A |
| TOTAL | $46,155 | $N/A | $N/A | $N/A |
| Non-Current Assets | ||||
| Other Non-Current Assets | 2,234 | 0 | 0 | 0 |
| TOTAL | $2,234 | $N/A | $N/A | $N/A |
| Total Assets | $48,389 | $N/A | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 8,793 | 0 | 0 | 0 |
| Accrued Expenses | 4,950 | N/A | N/A | N/A |
| TOTAL | $14,099 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 1,683 | 0 | 0 | 0 |
| TOTAL | $1,683 | $N/A | $N/A | $N/A |
| Total Liabilities | $15,782 | $N/A | $N/A | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | N/A | 17,052 | N/A | N/A |
| Common Shares | 1 | N/A | N/A | N/A |
| Retained earnings | -66,770 | N/A | N/A | N/A |
| Other shareholders' equity | -2 | 0 | 0 | 0 |
| TOTAL | $32,607 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $48,389 | $0 | $0 | $0 |